Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: Implications of a factor analysis of clustering

Metabolic Syndrome and Related Disorders

Volumn 7, Issue 2, 2009, Pages 89-96

  Mayer Davis, Elizabeth J ^a   Ma, Bo ^b   Lawson, Andrew ^b   D'Agostino Jr , Ralph B ^c   Liese, Angela D ^b   Bell, Ronny A ^c   Dabelea, Dana ^d   Dolan, Lawrence ^e   Pettitt, David J ^f   Rodriguez, Beatriz L ^g   Williams, Desmond ^h  

^a University of North Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d Global Health and Health Disparities   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF HAWAII   (United States)

^h NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FACTORIAL ANALYSIS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; AGE FACTORS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHILD; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; OBESITY; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 66749105142     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2008.0046     Document Type: Article

References (29)

1. Rodriguez BL, Fujimoto W, Mayer-Davis E, Imperatore G, Williams DE, Bell RA, Wadwa RP, Palla SL, Liu L, Kershnar A, Daniels S, Linder B. Prevalence of Cardiovascular Disease Risk Factors in U.S. Children and Adolescents with Diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care 2006;29:1891-1896.
2. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999-2000. Diabetes Care 2004;27:2438-2443.
3. SEARCH for Diabetes in Youth. a multicenter study of the prevalence, incidence and classif cation of diabetes mellitus in youth. Control Clin Trials 2004;25:458-471.
4. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28: 2289-2304.
5. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005;51:931-938.
6. Grundy SM. Does the metabolic syndrome exist? Diabetes Care 2006;29:1689-1692.
7. Kahn R. The metabolic syndrome (emperor) wears no clothes. Diabetes Care 2006;29:1693-1696.
8. Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, Falces C, Serrano-Rios M, Gabriel R, Shaw JE, Zimmet PZ, Haffner S. A single factor underlies the metabolic syndrome: a conf rmatory factor analysis 2. Diabetes Care 2006;29:113-122.
9. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006;83:1237-1247.
10. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: f ndings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-827.
11. Mayer-Davis EJ, Ma B, Lawson AB, D'Agostino R, Liese AD, Bell RA. Do Cardiovascular Disease (CVD) Risk Factors Cluster in Youth with Type 1A or Type 2 Diabetes? (Abstract). Diabetes 2006;55:A220-A221.
12. Goodman E, Dolan LM, Morrison JA, Daniels SR. Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation 2005;111:1970 -1977.
13. Chen W, Srinivasan S, Elkasabany A, Berenson G. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol 1999;150:667-674.
14. Lawlor DA, Ebrahim S, May M, Davey SG. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol 2004;159:1013-1018.
15. Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study. Am J Public Health 1992;82:1613-1620.
16. Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145: 439-444.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
18. Hai nli ne A, Jr., Miller D T, Mat her A. The Coronar y Drug Project. Role and methods of the Central Laboratory. Control Clin Trials. 1983;4:377-387.
19. Marcovina SM, Landin-Olsson M, Essen-Moller A, Palmer JP, Lernmark A. Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies. Int J Clin Lab Res 2000;30:21-26.
20. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. Fourth report on the diagnosis, evaluation, and treatment of high blood pressure in childrem and adolescents. Pediatrics 2004;114:555-576.
21. Hu LT, Bentler PM. Evaluating model fit. In Structural Equation Modeling: Concepts, Issues, and Applications. Hoyle RH, ed. Thousand Oaks, CA: Sage; 1995: 76-99.
22. Hu LT, Bentler PM. Fit indices in covariance structure modeling: Sensitivity to underparameterized model misspecif cation. Psycholog Methods 1998;3:424 - 453.
23. Shen BJ, Goldberg RB, Llabre MM, Schneiderman N. Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study. Ann Epidemiol 2006;16: 131-137.
24. Szadkowska A, Pietrzak I, Mianowska B, Bodalska-Lipinska J, Keenan HA, Toporowska-Kowalska E, Mlynarski W, Bodalski J. Insulin sensitivity in Type 1 diabetic children and adolescents. Diabet Med 2008;25:282-288.
25. Pambianco G, Costacou T, Orchard TJ. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate def nitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 2007;30:1248-1254.
26. Makinen V P, Forsblom C, Thorn LM, Waden J, Gordin D, Heikkila O, Hietala K, Kyllonen L, Kyto J, Rosengard-Barlund M, Saraheimo M, Tolonen N, Parkkonen M, Kaski K, la-Korpela M, Groop PH. Metabolic phenotypes, vascular complications and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes 2008;57:2480-2487.
27. Bonora E, Targher G, Alberiche M, Formentini G, Calcaterra F, Lombardi S, Marini F, Poli M, Zenari L, Raffaelli A, Perbellini S, Zenere MB, Saggiani F, Bonadonna RC, Muggeo M. Predictors of insulin sensitivity in Type 2 diabetes mellitus. Diabet Med 2002;19:535-542.
28. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M. The Metabolic Sy ndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004;21:52-58.
29. Liese AD, D'Agostino RB, Jr., Hamman RF, Kilgo PD, Lawrence JM, Liu LL, Loots B, Linder B, Marcovina S, Rodriguez B, Standiford D, Williams DE. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006;118:1510 -1518.